Trinity Biotech plc (TRIB)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 13.60M |
| Enterprise Value | 64.77M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.06 |
| Price/Book (mrq) | 5.11 |
| Enterprise Value/Revenue | 0.91 |
| Enterprise Value/EBITDA | -2.46 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.23 |
| 52-Week Change 3 | -64.75% |
| S&P500 52-Week Change 3 | 24.19% |
| 52 Week High 3 | 5.5000 |
| 52 Week Low 3 | 1.7800 |
| 50-Day Moving Average 3 | 2.0798 |
| 200-Day Moving Average 3 | 2.7732 |
Share Statistics
| Avg Vol (3 month) 3 | 98.92k |
| Avg Vol (10 day) 3 | 10k |
| Shares Outstanding 5 | 7.64M |
| Implied Shares Outstanding 6 | 7.64M |
| Float 8 | 69.35M |
| % Held by Insiders 1 | 29.31% |
| % Held by Institutions 1 | 39.28% |
| Shares Short (Apr 15, 2024) 4 | 1.86k |
| Short Ratio (Apr 15, 2024) 4 | 0.1 |
| Short % of Float (Apr 15, 2024) 4 | 0.04% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.02% |
| Shares Short (prior month Mar 15, 2024) 4 | 4.3k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | 1.19 |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jul 01, 2015 |
| Ex-Dividend Date 4 | Jun 05, 2015 |
| Last Split Factor 2 | 1:5 |
| Last Split Date 3 | Feb 23, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -42.26% |
| Operating Margin (ttm) | -25.98% |
Management Effectiveness
| Return on Assets (ttm) | -13.15% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 56.83M |
| Revenue Per Share (ttm) | 7.42 |
| Quarterly Revenue Growth (yoy) | -25.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | -14.16M |
| Net Income Avi to Common (ttm) | -36.87M |
| Diluted EPS (ttm) | -19.2600 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.69M |
| Total Cash Per Share (mrq) | 0.02 |
| Total Debt (mrq) | 54.86M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.60 |
| Book Value Per Share (mrq) | -3.12 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11.56M |
| Levered Free Cash Flow (ttm) | -11.02M |
© 2024 Yahoo. All rights reserved.